Log In
Print this Print this

Anti-MCL-1 Alphabody

  Manage Alerts
Collapse Summary General Information
Company Complix N.V.
DescriptionAnti-MCL1 alphabody targeting cancer
Molecular Target Myeloid leukemia cell differentiation protein (MCL1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today